Literature DB >> 8435392

Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies.

J J Harding1, M Egerton, R van Heyningen, R S Harding.   

Abstract

Data from two case control studies in Oxfordshire were combined and analysed. The combined study covered 1940 subjects, 723 cases, and 1217 controls, between the ages of 50 and 79 with a response rate of 97% for cases and 94% for controls. Diabetes was shown to be a powerful and highly significant risk factor for cataract with a relative risk of 5.04. More than 11% of cataracts in Oxfordshire are attributable to diabetes. The relative risk did not increase significantly with age within the range 50 to 79 years but was higher in females than in males. For females with diabetes the relative risk was 7.85 with 95% confidence interval from 4.30 to 14.3 compared with 3.42 with confidence interval from 2.05 to 5.71 for males with diabetes. Diabetes remained a powerful risk factor when other identified risk factors had been controlled for. No known mechanism for the development of diabetic complications provides an explanation for the excess risk in females. Combination of the two studies led to better estimates of the relative risk of glaucoma as a risk factor for cataract (3.96 with 95% confidence interval from 2.35 to 6.68). The relative risk appeared to be greater in women than in men but this difference was not statistically significant. There was no significant change in risk with age. Glaucoma is a powerful and independent risk factor for cataract in both sexes and may be responsible for 5% of all cataracts in our area.

Entities:  

Mesh:

Year:  1993        PMID: 8435392      PMCID: PMC504412          DOI: 10.1136/bjo.77.1.2

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  23 in total

1.  Late results of surgery on eyes with primary glaucoma and cataract.

Authors:  L Laatkainen
Journal:  Acta Ophthalmol (Copenh)       Date:  1971

2.  Comparison of cataract incidence in normal and glaucomatous population.

Authors:  R N Shaffer; G Rosenthal
Journal:  Am J Ophthalmol       Date:  1970-03       Impact factor: 5.258

3.  Role of glycosylation in protein disulfide formation and cataractogenesis.

Authors:  N H Ansari; Y C Awasthi; S K Srivastava
Journal:  Exp Eye Res       Date:  1980-07       Impact factor: 3.467

4.  Glucosylation of human lens protein and cataractogenesis.

Authors:  A Pande; W H Garner; A Spector
Journal:  Biochem Biophys Res Commun       Date:  1979-08-28       Impact factor: 3.575

5.  Epidemiological and other studies in the assessment of factors contributing to cataractogenesis.

Authors:  R M Clayton; J Cuthbert; J Seth; C I Phillips; R S Bartholomew; J M Reid
Journal:  Ciba Found Symp       Date:  1984

Review 6.  Diabetic and galactosaemic cataracts.

Authors:  P F Kador; J H Kinoshita
Journal:  Ciba Found Symp       Date:  1984

7.  Increased glycosylation of proteins from cataractous lenses in diabetes.

Authors:  K Kasai; T Nakamura; N Kase; T Hiraoka; R Suzuki; F Kogure; S I Shimoda
Journal:  Diabetologia       Date:  1983-07       Impact factor: 10.122

8.  Epidemiologic aspects of cataract surgery. III: Frequencies of diabetes and glaucoma in a cataract population.

Authors:  P Bernth-Petersen; E Bach
Journal:  Acta Ophthalmol (Copenh)       Date:  1983-06

9.  The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years.

Authors:  R Klein; B E Klein; S E Moss; M D Davis; D L DeMets
Journal:  Arch Ophthalmol       Date:  1984-04

10.  Senile lens changes and diabetes in two population studies.

Authors:  F Ederer; R Hiller; H R Taylor
Journal:  Am J Ophthalmol       Date:  1981-03       Impact factor: 5.258

View more
  41 in total

1.  Is month of birth associated with cataract in later life?

Authors:  J J Harding; R van Heyningen
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

2.  Long-term results of trabeculectomy in eyes that were initially successful.

Authors:  J T Wilensky; T C Chen
Journal:  Trans Am Ophthalmol Soc       Date:  1996

3.  Progression of diabetic retinopathy following cataract surgery: can it be prevented?

Authors:  D W Flanagan
Journal:  Br J Ophthalmol       Date:  1996-09       Impact factor: 4.638

4.  Retrobulbar blood flow in patients with cataract.

Authors:  M C Grieshaber; I Koçak; B Dubler; J Flammer; S Orgül
Journal:  Br J Ophthalmol       Date:  2006-08-02       Impact factor: 4.638

5.  Topical ocular hypotensive medication and lens opacification: evidence from the ocular hypertension treatment study.

Authors:  David C Herman; Mae O Gordon; Julia A Beiser; Leo T Chylack; Kathleen A Lamping; Oliver D Schein; Joern B Soltau; Michael A Kass
Journal:  Am J Ophthalmol       Date:  2006-11       Impact factor: 5.258

6.  Regulation of lens gap junctions by Transforming Growth Factor beta.

Authors:  Bruce A Boswell; Judy K VanSlyke; Linda S Musil
Journal:  Mol Biol Cell       Date:  2010-03-31       Impact factor: 4.138

7.  Diabetic cataract-pathogenesis, epidemiology and treatment.

Authors:  Andreas Pollreisz; Ursula Schmidt-Erfurth
Journal:  J Ophthalmol       Date:  2010-06-17       Impact factor: 1.909

8.  Mitochondrial oxygen metabolism in primary human lens epithelial cells: Association with age, diabetes and glaucoma.

Authors:  M Kubota; Y B Shui; M Liu; F Bai; A J Huang; N Ma; D C Beebe; C J Siegfried
Journal:  Free Radic Biol Med       Date:  2016-07-19       Impact factor: 7.376

9.  The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial.

Authors:  Morteza Entezari; Alireza Ramezani; Homayon Nikkhah; Mehdi Yaseri
Journal:  Int Ophthalmol       Date:  2016-03-14       Impact factor: 2.031

10.  Effect of a combination of carnosine and aspirin eye drops on streptozotocin -- induced diabetic cataract in rats.

Authors:  Qiong Shi; Hong Yan; Ming-Yong Li; John J Harding
Journal:  Mol Vis       Date:  2009-10-21       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.